Table of Contents
Hepatitis Research and Treatment
Volume 2011, Article ID 697162, 9 pages
http://dx.doi.org/10.1155/2011/697162
Research Article

Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand

1INSERM U1052, 151 Cours Albert Thomas, 69003 Lyon, France
2International Agency for Research on Cancer, 150 Cours Albert Thomas, Cedex 08, 69372 Lyon, France
3Departamento de Patología, Universidad de Antioquia, SIU, Carrera 51 no. 61-30, Medellín, Colombia
4Grupo de Gastrohepatología, Universidad de Antioquia, SIU, Carrera 51 no. 61-30, Medellín, Colombia
5Biomnis, Anatomie et Cytologie Pathologiques, 17/19 Avenue Tony Garnier, 69007 Lyon, France
6Department of Virology, Swedish Institute for Infectious Disease Control (Smittskyddsinstitutet, SMI), Solna, Sweden
7Cancer Control Unit, National Cancer Institute, 268/1 Rama VI Road, Bangkok 10400, Thailand
8Research Division, National Cancer Institute, Rama VI Road, Bangkok 10400, Thailand

Received 25 February 2011; Accepted 4 May 2011

Academic Editor: Patrick Soussan

Copyright © 2011 Olivier Galy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Kew, “Epidemiology of hepatocellular carcinoma,” Toxicology, vol. 181-182, pp. 35–38, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. A. M. Di Bisceglie, L. H. Simpson, M. T. Lotze, and J. H. Hoofnagle, “Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection,” Journal of Clinical Gastroenterology, vol. 19, no. 3, pp. 222–226, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. M. C. Hollstein, C. P. Wild, F. Bleicher et al., “p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand,” International Journal of Cancer, vol. 53, no. 1, pp. 51–55, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Y. Kuang, S. Lekawanvijit, N. Maneekarn et al., “Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 2, pp. 380–384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Songsivilai, T. Dharakul, and D. Kanistanon, “Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 5, pp. 505–507, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Tangkijvanich, P. Hirsch, A. Theamboonlers, I. Nuchprayoon, and Y. Poovorawan, “Association of hepatitis viruses with hepatocellular carcinoma in Thailand,” Journal of Gastroenterology, vol. 34, no. 2, pp. 227–233, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Thaikruea, S. Thongsawat, N. Maneekarn, D. Netski, D. L. Thomas, and K. E. Nelson, “Risk factors for hepatitis C virus infection among blood donors in northern Thailand,” Transfusion, vol. 44, no. 10, pp. 1433–1440, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. E. Nita, V. A. Alves, F. J. Carrilho, S. K. Ono-Nita, E. S. De Mello, and J. J. Gama-Rodrigues, “Molecular aspects of hepatic carcinogenesis,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 44, no. 1, pp. 39–48, 2002. View at Google Scholar · View at Scopus
  9. C. M. Chu and Y. F. Liaw, “Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline,” Journal of Hepatology, vol. 43, no. 3, pp. 411–417, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Mayerat, A. Mantegani, and P. C. Frei, “Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?” Journal of Viral Hepatitis, vol. 6, no. 4, pp. 299–304, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Orito, M. Mizokami, H. Sakugawa et al., “A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C,” Hepatology, vol. 33, no. 1, pp. 218–223, 2001. View at Publisher · View at Google Scholar
  12. S. Y. Kuang, P. E. Jackson, J. B. Wang et al., “Specific mutations of hepatitis B virus in plasma predict liver cancer development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 10, pp. 3575–3580, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. P. P. Anthony, “Hepatocellular carcinoma: an overview,” Histopathology, vol. 39, no. 2, pp. 109–118, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Buendia, “Genetics of hepatocellular carcinoma,” Seminars in Cancer Biology, vol. 10, no. 3, pp. 185–200, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. A. de La Coste, B. Romagnolo, P. Billuart et al., “Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 15, pp. 8847–8851, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Olivier, R. Eeles, M. Hollstein, M. A. Khan, C. C. Harris, and P. Hainaut, “The IARC TP53 database: new online mutation analysis and recommendations to users,” Human Mutation, vol. 19, no. 6, pp. 607–614, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Tannapfel and C. Wittekind, “Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis,” Virchows Archiv, vol. 440, no. 4, pp. 345–352, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Laurent-Puig, P. Legoix, O. Bluteau et al., “Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis,” Gastroenterology, vol. 120, no. 7, pp. 1763–1773, 2001. View at Google Scholar · View at Scopus
  19. F. Aguilar, S. P. Hussain, and P. Cerutti, “Aflatoxin B1 induces the transversion of G → T in codon 249 of the p53 tumor suppressor gene in human hepatocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 18, pp. 8586–8590, 1993. View at Google Scholar · View at Scopus
  20. D. Cougot, C. Neuveut, and M. A. Buendia, “HBV-induced carcinogenesis,” Journal of Clinical Virology, vol. 34, supplement 1, pp. S75–S78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Ming, S. S. Thorgeirsson, M. H. Gail et al., “Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China,” Hepatology, vol. 36, no. 5, pp. 1214–1220, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Ozturk, “Genetic aspects of hepatocellular carcinogenesis,” Seminars in Liver Disease, vol. 19, no. 3, pp. 235–242, 1999. View at Google Scholar · View at Scopus
  23. G. D. Kirk, O. A. Lesi, M. Mendy et al., “249ser TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma,” Oncogene, vol. 24, no. 38, pp. 5858–5867, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Chemin, D. Jeantet, A. Kay, and C. Trepo, “Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease,” Antiviral Research, vol. 52, no. 2, pp. 117–123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Norder, A. M. Courouce, P. Coursaget et al., “Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBAg subtypes,” Intervirology, vol. 47, no. 6, pp. 289–309, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Norder, B. Hammas, S. D. Lee et al., “Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen,” Journal of General Virology, vol. 74, no. 7, pp. 1341–1348, 1993. View at Google Scholar · View at Scopus
  27. M. Hussain, C. J. Chu, E. Sablon, and A. S. Lok, “Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants,” Journal of Clinical Microbiology, vol. 41, no. 8, pp. 3699–3705, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Vitvitski-Trepo, A. Kay, C. Pichoud et al., “Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection,” Hepatology, vol. 12, no. 6, pp. 1278–1283, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Galy, M. A. Petit, S. Benjelloun et al., “Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteins,” Cancer Letters, vol. 248, no. 1, pp. 81–88, 2007. View at Publisher · View at Google Scholar
  30. S. Kato, S. Y. Han, W. Liu et al., “Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8424–8429, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. H. J. Stirk, J. M. Thornton, and C. R. Howard, “A topological model for hepatitis B surface antigen,” Intervirology, vol. 33, no. 3, pp. 148–158, 1992. View at Google Scholar · View at Scopus
  32. H. Fujii, K. Moriyama, N. Sakamoto et al., “Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus,” Biochemical and Biophysical Research Communications, vol. 184, no. 3, pp. 1152–1157, 1992. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Grethe, M. Monazahian, I. Bohme, and R. Thomssen, “Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject,” Journal of Virology, vol. 72, no. 9, pp. 7692–7696, 1998. View at Google Scholar · View at Scopus
  34. S. Lipigorngoson, P. Limtrakul, M. Suttajit, and T. Yoshizawa, “In-house direct cELISA for determining aflatoxin B in Thai corn and peanuts,” Food Additives and Contaminants, vol. 20, no. 9, pp. 838–845, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. J. C. Sheu, G. T. Huang, L. N. Shih et al., “Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma,” Gastroenterology, vol. 103, no. 4, pp. 1322–1327, 1992. View at Google Scholar · View at Scopus
  36. Y. Y. Zhang, B. G. Hansson, L. S. Kuo, A. Widell, and E. Nordenfelt, “Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg,” Hepatology, vol. 17, no. 4, pp. 538–544, 1993. View at Google Scholar · View at Scopus
  37. C. Brechot, V. Thiers, D. Kremsdorf, B. Nalpas, S. Pol, and P. Paterlini-Brechot, “Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”?” Hepatology, vol. 34, no. 1, pp. 194–203, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Pollicino, G. Squadrito, G. Cerenzia et al., “Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection,” Gastroenterology, vol. 126, no. 1, pp. 102–110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Theamboonlers, P. Tangkijvanich, C. Pramoolsinsap, and Y. Poovorawan, “Genotypes and subtypes of hepatitis B virus in Thailand,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 29, no. 4, pp. 786–791, 1998. View at Google Scholar
  40. A. M. Roque-Afonso, M. P. Ferey, D. Belkhiri, and E. Dussaix, “HBs antigen mutants: prevalence, clinical and diagnostic implications,” Pathologie Biologie, vol. 53, no. 8-9, pp. 563–568, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. F. Liaw, “Role of hepatitis C virus in dual and triple hepatitis virus infection,” Hepatology, vol. 22, no. 4 I, pp. 1101–1108, 1995. View at Google Scholar · View at Scopus
  42. C. M. Shih, S. J. Lo, T. Miyamura, S. Y. Chen, and Y. H. Lee, “Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells,” Journal of Virology, vol. 67, no. 10, pp. 5823–5832, 1993. View at Google Scholar · View at Scopus